Mystery Solved programme

Download programme

Register
Hour
Location 		Title Location
16:00 - 16:10
 Opening
16:10 - 16:40
 Altered EBV-specific immune control in MS; involved in EBV clearance or in autoimmunity
Christian Münz
16:40 - 17:10
 B cell differentiation and EBV infection, role of B cells in lytic replication.
Micah Luftig
17:10 - 17:40
 EBV implication in New MS Disease Activity
Prof. Amit Bar-Or Simon Thebault
17:40 - 18:10
 EBV-infected B cells in the central nervous system
Roberta Magliozzi
18:10 - 18:20
 Break
18:20 - 18:50
 Using Spontaneous Lymphoblastic Cell Lines (SLCLs) to Model Pathogenic EBV-Infected B cells in MS
Paul Lieberman
18:50 - 19:20
 Isolation and expansion of endogenous EBV-infected B cells for EBV genome analysis.
Pentti Tienari
19:20 - 19:50
 EBV lytic replication and MS: clinical trials.
Øivind Torkildsen
19:50 - 20:20
 Presentation of the Behind-MS EU Consortium and a few suggestions for multicentric preclinical studies on EBV and MS
Henri Jacques Delecluse
20:20 - 20:30
 Closing remarks
Hour
Location 		Title Location
16:00 - 16:10
 Opening
16:10 - 16:40
 Pathogenic antibodies against EBV proteins
Jan Lünemann
16:40 - 17:10
 The anti-EBV TCR repertoire
Tilman Schneider-Hohendorf
17:10 - 17:40
 EBV epitope presentation to T cells
Roland Martin Natalia Drosu
17:40 - 18:10
 Mimicry to GlialCAM to anoctamin 2 and to alpha-chrystallin B
Tobias Lanz Olivia Thomas
18:10 - 18:20
 Break
18:20 - 18:50
 Actors in mimicry control: NK, HLA and CMV
Hannes Vietzen Paul Rommer
18:50 - 19:20
 Antiviral therapies
Prof. Dr Gavin Giovannoni
19:20 - 19:50
 Anti-EBV vaccines
Prof Dr Jeffrey Cohen
19:50 - 20:20
 Open discussion: - New therapeutic strategies in early MS - New strategies/perspectives in causal MS research
20:20 - 20:30
 Closing remarks
20:45 - 21:30
 HIGHLIGHTS & INSIGHTS: A RECAP OF THE TWO-DAY WEBINAR
Patrick Vanderdonckt